Testosterone metabolites in patients reduce the levels of very long chain fatty acids accumulated in X-adrenoleukodystrophic fibroblasts

A. Petroni, N. Papini, M. Blasevich, V. Magnaghi, I. Cavarretta, C. Galli, R. C. Melcangi

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Testosterone metabolites (dihydrotestosterone, DHT) and 5α-androstan-3α,17β-diol (3α-diol), but not testosterone itself, were shown to reduce the levels of very long chain fatty acids which accumulate in cultured skin fibroblasts from X-adrenoleukodystrophic patients (X-ALD). In addition, in X-ALD fibroblasts, testosterone is less actively converted into DHT vs. controls (skin fibroblasts retrieved from normal subjects) whereas the additional conversion of DHT to the final product 3α-diol is enhanced. This is the first report of altered testosterone metabolism in X-ALD fibroblasts and of the effects of androgens in lowering the abnormal accumulation of very long chain fatty acids in this type of cells. Copyright (C) 2000 Elsevier Science Ireland Ltd.

Original languageEnglish
Pages (from-to)139-142
Number of pages4
JournalNeuroscience Letters
Volume289
Issue number2
DOIs
Publication statusPublished - Aug 4 2000

Fingerprint

Testosterone
Dihydrotestosterone
Fatty Acids
Fibroblasts
Skin
Androgens

Keywords

  • 3α-Diol
  • 5α-Androstan-17β-ol-3-one
  • 5α-Androstan-3α,17β-diol
  • Dihydrotestosterone
  • Testosterone
  • Very long chain fatty acids
  • X-adrenoleukodystrophy

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Testosterone metabolites in patients reduce the levels of very long chain fatty acids accumulated in X-adrenoleukodystrophic fibroblasts. / Petroni, A.; Papini, N.; Blasevich, M.; Magnaghi, V.; Cavarretta, I.; Galli, C.; Melcangi, R. C.

In: Neuroscience Letters, Vol. 289, No. 2, 04.08.2000, p. 139-142.

Research output: Contribution to journalArticle

Petroni, A. ; Papini, N. ; Blasevich, M. ; Magnaghi, V. ; Cavarretta, I. ; Galli, C. ; Melcangi, R. C. / Testosterone metabolites in patients reduce the levels of very long chain fatty acids accumulated in X-adrenoleukodystrophic fibroblasts. In: Neuroscience Letters. 2000 ; Vol. 289, No. 2. pp. 139-142.
@article{0713eccd158e469e9a7c2ad3d89a3d6b,
title = "Testosterone metabolites in patients reduce the levels of very long chain fatty acids accumulated in X-adrenoleukodystrophic fibroblasts",
abstract = "Testosterone metabolites (dihydrotestosterone, DHT) and 5α-androstan-3α,17β-diol (3α-diol), but not testosterone itself, were shown to reduce the levels of very long chain fatty acids which accumulate in cultured skin fibroblasts from X-adrenoleukodystrophic patients (X-ALD). In addition, in X-ALD fibroblasts, testosterone is less actively converted into DHT vs. controls (skin fibroblasts retrieved from normal subjects) whereas the additional conversion of DHT to the final product 3α-diol is enhanced. This is the first report of altered testosterone metabolism in X-ALD fibroblasts and of the effects of androgens in lowering the abnormal accumulation of very long chain fatty acids in this type of cells. Copyright (C) 2000 Elsevier Science Ireland Ltd.",
keywords = "3α-Diol, 5α-Androstan-17β-ol-3-one, 5α-Androstan-3α,17β-diol, Dihydrotestosterone, Testosterone, Very long chain fatty acids, X-adrenoleukodystrophy",
author = "A. Petroni and N. Papini and M. Blasevich and V. Magnaghi and I. Cavarretta and C. Galli and Melcangi, {R. C.}",
year = "2000",
month = "8",
day = "4",
doi = "10.1016/S0304-3940(00)01296-9",
language = "English",
volume = "289",
pages = "139--142",
journal = "Neuroscience Letters",
issn = "0304-3940",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Testosterone metabolites in patients reduce the levels of very long chain fatty acids accumulated in X-adrenoleukodystrophic fibroblasts

AU - Petroni, A.

AU - Papini, N.

AU - Blasevich, M.

AU - Magnaghi, V.

AU - Cavarretta, I.

AU - Galli, C.

AU - Melcangi, R. C.

PY - 2000/8/4

Y1 - 2000/8/4

N2 - Testosterone metabolites (dihydrotestosterone, DHT) and 5α-androstan-3α,17β-diol (3α-diol), but not testosterone itself, were shown to reduce the levels of very long chain fatty acids which accumulate in cultured skin fibroblasts from X-adrenoleukodystrophic patients (X-ALD). In addition, in X-ALD fibroblasts, testosterone is less actively converted into DHT vs. controls (skin fibroblasts retrieved from normal subjects) whereas the additional conversion of DHT to the final product 3α-diol is enhanced. This is the first report of altered testosterone metabolism in X-ALD fibroblasts and of the effects of androgens in lowering the abnormal accumulation of very long chain fatty acids in this type of cells. Copyright (C) 2000 Elsevier Science Ireland Ltd.

AB - Testosterone metabolites (dihydrotestosterone, DHT) and 5α-androstan-3α,17β-diol (3α-diol), but not testosterone itself, were shown to reduce the levels of very long chain fatty acids which accumulate in cultured skin fibroblasts from X-adrenoleukodystrophic patients (X-ALD). In addition, in X-ALD fibroblasts, testosterone is less actively converted into DHT vs. controls (skin fibroblasts retrieved from normal subjects) whereas the additional conversion of DHT to the final product 3α-diol is enhanced. This is the first report of altered testosterone metabolism in X-ALD fibroblasts and of the effects of androgens in lowering the abnormal accumulation of very long chain fatty acids in this type of cells. Copyright (C) 2000 Elsevier Science Ireland Ltd.

KW - 3α-Diol

KW - 5α-Androstan-17β-ol-3-one

KW - 5α-Androstan-3α,17β-diol

KW - Dihydrotestosterone

KW - Testosterone

KW - Very long chain fatty acids

KW - X-adrenoleukodystrophy

UR - http://www.scopus.com/inward/record.url?scp=0033934566&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033934566&partnerID=8YFLogxK

U2 - 10.1016/S0304-3940(00)01296-9

DO - 10.1016/S0304-3940(00)01296-9

M3 - Article

C2 - 10904139

AN - SCOPUS:0033934566

VL - 289

SP - 139

EP - 142

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

IS - 2

ER -